Immune-mediated rejection of donor tissues is one of the largest challenges in transplant biology. While routine biopsy to monitor transplanted organs can be informative, this procedure is invasive and carries several risks. In this episode, Prashanth Vallabhajosyula and colleagues evaluated changes in transplant-derived exosomes in murine models and human transplant recipients. Their work indicates that changes in donor-derived exosomes can be used to noninvasively monitor transplant rejection.
ReNeuron breakthrough – Exosome tech delivers therapeutic proteins to hard to access region of brain
October 12, 2021
September 24, 2021
Good things come in small packages: roles of exosomes as therapy delivery tools, therapeutic targets and potential biomarkers
March 23, 2021
December 3, 2020